CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $80 | +6.7% | 3,705 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $75 | -99.9% | 3,705 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $95,000 | -20.2% | 3,705 | -38.4% | 0.00% | 0.0% |
| Q4 2021 | $119,000 | -40.8% | 6,010 | -41.1% | 0.00% | -42.9% |
| Q3 2021 | $201,000 | -10.3% | 10,200 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $224,000 | -7.8% | 10,200 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $243,000 | -9.0% | 10,200 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $267,000 | +50.0% | 10,200 | 0.0% | 0.01% | +37.5% |
| Q3 2020 | $178,000 | +3.5% | 10,200 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $172,000 | – | 10,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |